Basic Information
| LncRNA/CircRNA Name | HANR |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qRT-PCR |
| Sample | glioma tissues and cell Lines |
| Expression Pattern | up-regulated |
| Function Description | LncRNA HANR is upregulated in glioma, which is closely correlated with metastasis and poor prognosis of glioma patients. In addition, HANR aggravates the progression of glioma by negatively regulating miRNA-335. |
| Pubmed ID | 32016979 |
| Year | 2020 |
| Title | LncRNA HANR aggravates the malignant progression of glioma via targeting miRNA-335 |
External Links
| Links for HANR | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |